Elsevier expands article submission screening tool to strengthen research credibility
2026년 3월 18일
‘Check Integrity’ Tool Screens Research Articles Prior to Journal Publication to Strengthen Research Integrity and Publishing Quality
Elsevier has expanded its Check Integrity screening tool across nearly 2,000 of its journals to help identify potential ethical issues in research papers before publication, following a successful pilot phase.
The tool is designed to detect potential breaches of publishing ethics policies, such as unauthorized authorship changes and editorial conflicts of interest so that these can be addressed by a team of experts.
So far, a significant number of potential issues raised have led to corrective action to ensure compliance with our ethics policies, demonstrating the tool’s value in preventing future corrections to the record.
Check Integrity reviews submissions automatically and flags concerns for specialist integrity analysts, who assess the findings and take action if needed. This allows editors to focus on evaluating credible research while improving efficiency and trust in the publishing process.
Laura Hassink, MD of STM Journals, said: “Check Integrity represents a meaningful leap in safeguarding the integrity of the research we publish. By handling the screening and initial communications, Check Integrity frees editors to focus on evaluating high-quality, authentic research, making the publication process faster and more reliable for authors and readers alike.”
The tool is designed to adapt as new risks emerge and helps address growing pressures on researchers and editors as submission volumes increase.
Prof. Sarah Spencer, Co-Editor-in-Chief of Neuroscience journal at RMIT University, added: “The Check Integrity tool is a fantastic weapon in our arsenal against those who would try to cheat the system.”
Check Integrity is part of Elsevier’s broader investment in technology and expert oversight to protect research integrity and maintain confidence in academic publishing.
엘스비어 소개
엘스비어는 첨단 정보와 의사결정 지원 분야의 글로벌 선도 기업으로 100년 넘게 과학과 헬스케어의 발전을 지원하며 인류 진보에 기여해 왔습니다. 우리는 170개국 이상에서 학술 및 기업 연구 커뮤니티, 의사, 간호사, 미래의 의료 전문가와 교육자들을 지원합니다. 근거에 기반한 신뢰할 수 있는 과학·의학 콘텐츠와 최첨단 AI 기술을 결합해 중요한 통찰과 혁신적인 솔루션을 제공해, 의미있는 성과를 이루도록 돕고 있습니다. 또한 다양성과 지속 가능성을 제품과 기업 문화 전반에 내재화하며, 우리가 속한 커뮤니티와 협력합니다. 엘스비어 재단은 전 세계에서 연구와 보건 파트너십을 지원합니다.
엘스비어는 전문가 및 기업 고객에게 정보 기반의 분석과 의사결정 도구를 제공하는 글로벌 기업 RELX의 일원입니다. 자세한 내용은 www.elsevier.com에서 확인할 수 있으며, 소셜미디어 @elsevierconnect를 통해 최신 소식을 받아보실 수 있습니다.
연락처
